NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the E ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Preliminary Data Shows Platform Generated Over $1.36 Million in Just 14 Days; Daily Revenue Velocity Accelerating Rapidly ...

LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug ...

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / As the market has paid increasing attention to, and begun revaluing, SMX's potential across plastics, gold, rare earths, and hardware ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

You hear about the flu vaccine, the COVID-19 vaccine, even the pneumonia vaccine, but in 2023, the FDA approved the first RSV ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

HERNDON, VA / ACCESS Newswire / December 15, 2025 / Out of 28 bidders, the U.S. Department of the Treasury has awarded ThinkTrends a $26 million prime contract under a multiple-award IDIQ. Through ...

France is creating a last-minute hurdle for a major trade deal between the European Union and the Mercosur bloc. European ...